Sex and the patient with cardiovascular risk factors: focus on sildenafil (Q34117930)

31 July 2017

1 reference

title

Sex and the patient with cardiovascular risk factors: focus on sildenafil (English)

1 reference

31 July 2017

1 reference

Kloner RA

1

1 reference

PubMed ID

11137498

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

American Journal of Medicine

31 July 2017

1 reference

31 July 2017

109 Suppl 9A

1 reference

31 July 2017

13S-21S; discussion 29S-30S

1 reference

Impaired glucose tolerance and the likelihood of nonfatal stroke and myocardial infarction: the Third National Health and Nutrition Examination Survey.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

The Framingham Study: ITS 50-year legacy and future promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Physical exertion as a trigger of myocardial infarction and sudden cardiac death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Cardiovascular effects of sildenafil citrate and recommendations for its use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Sexual activity triggering myocardial infarction. One less thing to worry about.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Myocardial ischemia during sexual activity in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Overall cardiovascular profile of sildenafil citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Effects of sildenafil citrate on human hemodynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Hemodynamic effects of sildenafil in men with severe coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900656-2

10.1016/S0002-9343(00)00656-2

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11137498